Tweet
AllSeq is proud to be a media partner for SelectBio’s upcoming “Next Generation Sequencing & Single Cell Analysis” conference that will be right here in San Diego on September 28th-30th. One of the benefits (in addition to the 15% discount we were able to negotiate for our readers) was the opportunity to interview a few of the keynote speakers. Check out our interviews with Dr. Jennifer Friedman from the Rady Children's Hospital in San Diego and Dr. Nazneen Aziz from the Phoenix Children’s Hospital. We ask both of them about how they’re using NGS in a clinical setting and their thoughts on what’s preventing it from being more widely adopted.
-
The sequencing world is rapidly changing due to declining costs, enhanced accuracies, and the advent of newer, cutting-edge instruments. Equally important to these developments are improvements in sequencing analysis, a process that converts vast amounts of raw data into a comprehensible and meaningful form. This complex task requires expertise and the right analysis tools. In this article, we highlight the progress and innovation in sequencing analysis by reviewing several of the...05-06-2024, 07:48 AM -
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist...04-22-2024, 07:01 AM